Skip to content

Novaxil Plus

by Rompharm Company SRL Romania EUDAMED

Ref NOVAXIL PLUSModel HIACON_IAPW EMDN P900402

Regulatory status

as of 26 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/MDD NumberB-05944728007475 Basic UDI-DIDate13 May 2022RegisteredStatusActive

Coverage

1 jurisdiction

SwedenFinlandFinlandSwedenFinlandFinlandSwedenSwedenLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyGermanyPolandPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaPolandFranceFranceAustriaHungaryRomaniaFranceFranceSloveniaBulgariaPortugalSpainSpainItalySpainSpainCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not known
  • Not covered

European Union — CE/MDD Expiring

Certificates: none listed in EUDAMED

Specification

EUDAMED · synced 22 Oct 2026

Device Name
Hyaluronate+Chondroitin_intraarticular
Model / Reference
HIACON_IAPW, NOVAXIL PLUS
Primary DI / UDI-DI
05944728007475
Basic UDI-DI
B-05944728007475
EMDN Code
P900402 Resorbable filling and reconstruction devices
Device Class
Class III
Market of Registration
Poland

Manufacturer details

EUDAMED SRN
RO-MF-000002517

Other devices from Rompharm Company SRL

See all devices from Rompharm Company SRL →

Properties & raw data

Show properties, registry sources and raw records
  • Sterile
  • Implantable
  • Animal Tissues
Other properties (8)
  • Reusable: No
  • Contains Latex: No
  • Reprocessed: No
  • Human-derived: No
  • Human Tissues: No
  • Administering Medicine: No
  • Measuring Function: No
  • Incorporates Medicinal Product: No

Sources (1)

  • EUDAMED d5f758c5-21b3-42c0-b1e2-3dd85993b203 61 fields · synced 22 Oct 2026